Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention.
Anticancer Res. 2011 Feb;31(2):607-11.
Garland CF, French CB, Baggerly LL, Heaney RP.
Abstract
Background: Studies indicate that intake of vitamin D in the range from 1,100 to 4,000 IU/d and a serum 25-hydroxyvitamin D concentration [25(OH)D] from 60-80 ng/ml may be needed to reduce cancer risk. Few community-based studies allow estimation of the dose-response relationship between oral intake of vitamin D and corresponding serum 25(OH)D in the range above 1,000 IU/d.
Materials and Methods: A descriptive study of serum 25(OH)D concentration and self-reported vitamin D intake in a community-based cohort (n = 3,667, mean age 51.3 ± 13.4 y).
Results: Serum 25(OH)D rose as a function of self-reported vitamin D supplement ingestion in a curvilinear fashion, with no intakes of 10,000 IU/d or lower producing 25(OH)D values above the lower-bound of the zone of potential toxicity (200 ng/ml). Unsupplemented all-source input was estimated at 3,300 IU/d. The supplemental dose ensuring that 97.5% of this population achieved a serum 25(OH)D of at least 40 ng/ml was 9,600 IU/d.
Conclusion: Universal intake of up to 40,000 IU vitamin D per day is unlikely to result in vitamin D toxicity.
Abstract Source: https://www.ncbi.nlm.nih.gov/pubmed/21378345
Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention.
Garland CF, French CB, Baggerly LL, Heaney RP.
Anticancer Res. 2011 Feb;31(2):607-11.
PMID: 21378345